User profiles for Cécile Tromeur

Cecile Tromeur

Verified email at chu-brest.fr
Cited by 2433

Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open …

…, O Sitbon, F Parent, R Trésorier, C Tromeur… - The Lancet …, 2022 - thelancet.com
Background Riociguat and balloon pulmonary angioplasty (BPA) are treatment options for
inoperable chronic thromboembolic pulmonary hypertension (CTEPH). However, randomised …

Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension

…, O Sanchez, A Seferian, C Tromeur… - American journal of …, 2021 - atsjournals.org
Rationale: The relationship between the initial treatment strategy and survival in pulmonary
arterial hypertension (PAH) remains uncertain. Objectives: To evaluate the long-term survival …

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an …

…, C Schweizer, H van der Straaten, C Tromeur… - The Lancet, 2022 - thelancet.com
Background Pregnancy-related venous thromboembolism is a leading cause of maternal
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …

Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France

A Delluc, C Tromeur, F Le Ven… - Thrombosis and …, 2016 - thieme-connect.com
In 1998 we estimated the incidence of venous thromboembolism (VTE) to be 1.8/1,000 per
year. The aim of this study was to compare current VTE incidence to that observed in 1998. …

Prevalence of pulmonary embolism among patients with COPD hospitalized with acutely worsening respiratory symptoms

…, C Hoffmann, L Bressollette, M Nonent, C Tromeur… - Jama, 2021 - jamanetwork.com
Importance The prevalence of pulmonary embolism in patients with chronic obstructive
pulmonary disease (COPD) and acutely worsening respiratory symptoms remains uncertain. …

Portopulmonary hypertension in the current era of pulmonary hypertension management

…, S Renard, D Horeau-Langlard, C Tromeur… - Journal of …, 2020 - Elsevier
Background & Aims Long-term outcomes in portopulmonary hypertension (PoPH) are poorly
studied in the current era of pulmonary hypertension management. We analysed the effect …

[HTML][HTML] Computed tomography pulmonary angiography versus ventilation-perfusion lung scanning for diagnosing pulmonary embolism during pregnancy: a …

C Tromeur, LM van der Pol, PY Le Roux… - …, 2019 - ncbi.nlm.nih.gov
Differences between computed tomography pulmonary angiography and ventilation-perfusion
lung scanning in pregnant patients with suspected acute pulmonary embolism are not well…

Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation

…, B Bondue, P Bonniaud, C Tromeur… - European …, 2021 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and deadly interstitial lung disease
(ILD). Over the past decade, familial occurrence of IPF led to the identification of genetic …

Serum and pulmonary uric acid in pulmonary arterial hypertension

…, X Jaďs, V Cottin, A Chaouat, C Tromeur… - European …, 2021 - Eur Respiratory Soc
Previous studies have suggested an association between uric acid (UA) and the severity of
pulmonary arterial hypertension (PAH), but it is unknown whether UA contributes to disease …

Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID‐19 patients

…, E L'HER, S ANSART, C TROMEUR… - Journal of Medical …, 2021 - Wiley Online Library
Little is known on the association between clinical factors and coronavirus disease 2019 (COVID‐19)
more than 15 days after diagnosis. We conducted a multicentric prospective cohort …